Prostate cancer
Open
Phase 1
This trial is looking at having saruparib or darolutamide before surgery to remove prostate cancer. It is also looking at the combination of saruparib and darolutamide before surgery.
This trial is for men whose prostate cancer:
is recently diagnosed
hasn’t spread outside the (localised prostate cancer) and
has a higher risk of spreading
Recruitment start: 21 September 2023
Recruitment end: 30 September 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Simon Pacey
AstraZeneca
Last reviewed: 04 Jun 2025
CRUK internal database number: 19501